Literature DB >> 17010589

Genes, environment and immunity in the development of rheumatoid arthritis.

Lars Klareskog1, Leonid Padyukov, Johan Rönnelid, Lars Alfredsson.   

Abstract

The combined role of genes, environment and immunity in the development of rheumatoid arthritis (RA) has been the subject of recent investigations. New data support a gene-environment interaction between smoking and the MHC class II HLA-DRB1 shared epitope (SE) genes in anti-citrulline antibody (anti-CP(+)) RA but not in anti-CP(-) disease. These data from genetic epidemiology, together with information on citrullination in the lungs of smokers, have prompted the formulation of a new etiological hypothesis for anti-CP(+) RA, suggesting that smoking in the context of HLA-DR SE might trigger immunity to citrulline-modified proteins and that this immunity, after several years, might cause arthritis.

Entities:  

Mesh:

Year:  2006        PMID: 17010589     DOI: 10.1016/j.coi.2006.06.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  63 in total

1.  The problems and promises of research into human immunology and autoimmune disease.

Authors:  Bart O Roep; Jane Buckner; Stephen Sawcer; Rene Toes; Frauke Zipp
Journal:  Nat Med       Date:  2012-01-06       Impact factor: 53.440

Review 2.  Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review.

Authors:  Emilio Martin-Mola; Alejandro Balsa; Rosario García-Vicuna; Juan Gómez-Reino; Miguel Angel González-Gay; Raimon Sanmartí; Estíbaliz Loza
Journal:  Rheumatol Int       Date:  2016-06-06       Impact factor: 2.631

Review 3.  Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Authors:  Jeffrey A Sparks; Karen H Costenbader
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

4.  Slc11a1 (Nramp-1) gene modulates immune-inflammation genes in macrophages during pristane-induced arthritis in mice.

Authors:  Mara A Correa; Tatiane Canhamero; Andrea Borrego; Iana S S Katz; José R Jensen; José Luiz Guerra; Wafa H K Cabrera; Nancy Starobinas; Jussara G Fernandes; Orlando G Ribeiro; Olga M Ibañez; Marcelo De Franco
Journal:  Inflamm Res       Date:  2017-07-01       Impact factor: 4.575

Review 5.  TLRs, future potential therapeutic targets for RA.

Authors:  Hatem A Elshabrawy; Abdul E Essani; Zoltán Szekanecz; David A Fox; Shiva Shahrara
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

Review 6.  Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?

Authors:  Jose U Scher; Walter A Bretz; Steven B Abramson
Journal:  Curr Opin Rheumatol       Date:  2014-07       Impact factor: 5.006

Review 7.  Rheumatoid arthritis: a view of the current genetic landscape.

Authors:  M J H Coenen; P K Gregersen
Journal:  Genes Immun       Date:  2008-11-06       Impact factor: 2.676

8.  Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor.

Authors:  Alejandro Balsa; Arancha Cabezón; Gisela Orozco; Tatiana Cobo; Eugenia Miranda-Carus; Miguel Angel López-Nevot; José Luis Vicario; Emilio Martín-Mola; Javier Martín; Dora Pascual-Salcedo
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

9.  Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Authors:  H Bacquet-Deschryver; F Jouen; M Quillard; J F Ménard; V Goëb; T Lequerré; O Mejjad; A Daragon; F Tron; X Le Loët; O Vittecoq
Journal:  J Clin Immunol       Date:  2008-06-28       Impact factor: 8.317

10.  Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

Authors:  Steven K Lundy; David A Fox
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.